KS
Karam Singh Babra
About Karam Singh Babra
Data last updated:
Karam Singh Babra is a Director at Biocordis Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Biocordis Pharmaceuticals Private Limited reported revenue of ₹97.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biocordis Pharmaceuticals Private Limited U24232CH2011PTC033230 | Director | 06 Sep 2011 | 2011 | ₹97.5 Lakh (FY 2025) | Active |
Board colleagues of Karam Singh Babra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anurag Bhatia | 02397243 | Biocordis Pharmaceuticals Private Limited | Director |
| Deepika Bhatia | 10961166 | Biocordis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karam Singh Babra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karam Singh Babra
Karam Singh Babra currently holds 1 directorship: Biocordis Pharmaceuticals Private Limited (Director, since 06 Sep 2011, revenue ₹97.5 Lakh (FY 2025)).
Karam Singh Babra was first appointed on 06 Sep 2011 as Director at Biocordis Pharmaceuticals Private Limited.
The current boards of Karam Singh Babra's companies include Anurag Bhatia (Biocordis Pharmaceuticals Private Limited), Deepika Bhatia (Biocordis Pharmaceuticals Private Limited).